Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-08-002191
Filing Date
2008-10-14
Accepted
2008-10-14 17:15:47
Documents
7
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 URIGEN PHARMACEUTICALS, INC. form10k.htm 10-K 4373026
2 EXHIBIT 21.1 ex211.htm EX-21.1 3814
3 EXHIBIT 23.1 ex231.htm EX-23.1 4008
4 EXHIBIT 31.1 ex311.htm EX-31.1 12256
5 EXHIBIT 31.2 ex312.htm EX-31.2 12555
6 EXHIBIT 32.1 ex321.htm EX-32.1 7717
7 EXHIBIT 32.2 ex322.htm EX-32.2 8225
  Complete submission text file 0001013762-08-002191.txt   4423214
Mailing Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010
Business Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010 (650) 697-1900
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-22987 | Film No.: 081123188
SIC: 2834 Pharmaceutical Preparations